|
sterol biosynthesis inhibitor
|
CHEBI_83317 |
|
|
EC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor
|
CHEBI_62089 |
|
|
choroideremia
|
DOID_9821 |
|
|
choroid disease
|
DOID_1417 |
|
|
partial central choroid dystrophy
|
DOID_9822 |
|
|
hereditary choroidal atrophy
|
DOID_9794 |
|
|
neonatal abstinence syndrome
|
DOID_9828 |
|
|
withdrawal disorder
|
DOID_0060001 |
|
|
radioulnar synostosis
|
DOID_9827 |
|
|
optic disk drusen
|
DOID_13561 |
|
|
histamine releasing agent
|
CHEBI_75298 |
|
|
bile reflux
|
DOID_12237 |
|
|
biliary tract disease
|
DOID_9741 |
|
|
primary biliary cholangitis
|
DOID_12236 |
|
|
liver cirrhosis
|
DOID_5082 |
|
|
cascade stomach
|
DOID_12234 |
|
|
aspergillosis
|
DOID_13564 |
|
|
somatostatin receptor agonist
|
CHEBI_177023 |
|
|
EC 6.1.1.6 (lysine--tRNA ligase) inhibitor
|
CHEBI_167677 |
|
|
impetigo
|
DOID_8504 |
|
